Plumeria (Apocynaceae) is a genus comprising mostly of lactiferous trees and deciduous shrubs. Plumeria obtusa L. is a widely available but pharmacologically lesser explored species of this genus. Thus, present research was undertaken to determine the phytochemical constituents and the antioxidant potential of the methanol extract and fractions of the plant. The antioxidant potential was determined using 1,1-diphenyl-2-picrylhydrazyl radical scavenging and inhibition of lipid peroxidation assay.
Estimation Based on Emission Wavelength of Dabigatran Etexilate Mesylate in Bulk and Capsule Dosage Form
propanoate is a selective anticoagulant, used as stoke and systemic embolism in patient with atrial fibrillation. Literature survey revealed that, few methods were reported for quantification of DAB by UV/Vis spectrophotometry [1, 2] and RP-HPLC [3, 4] . To the best of our knowledge, no method reported on the use of spectrofluorimetry for the quantification of DAB. Spectrofluorimetry has assumed a major role in drug analysis because of its greater sensitivity and selectivity than absorption spectrophotometry [5] [6] [7] [8] [9] [10] [11] . Hence, we aimed to develop and validate a simple, precise, accurate, selective and high sensitive spectrofluorimetric method for the estimation of DAB in pharmaceutical dosage form.
Dabigatran etexilate mesylate (DAB) pure drug was obtained as gift samples from Neuland Laboratories Limited, Hyderabad, India. Brand name is Pradaxa 110 mg, Boehringer Ingelheim Pharma, India. Methanol was purchased from Qualigens, Mumbai. Hydrochloric acid, glacial acetic acid, sodium hydroxide, DMSO, DMF, acetonitrile and ethanol was purchased from S.d. fine-Chem Ltd., Mumbai, India. The fluorescence spectra and measurements were recorded using Shimadzu RF-5301 PC Spectrofluorophotometer, equipped with 150 watt Xenon arc lamp, 1 cm nonfluorescence quartz cell was used, connected to RFPC software. DAB molecule contains polycyclic aromatic systems like pyridine ring and benzodiazolin ring, in which more π electrons are available to exhibit fluorescence ( fig. 1 ). For spectrofluorimetric method purpose, various solvents were investigated such as acetonitrile, methanol, DMSO, ethanol, DMF and different buffer systems. The fluorescence intensity of DAB was found only in DMSO solvent. Hence, we selected DMSO as solvent for quantification of DAB in bulk and pharmaceutical formulation at emission wavelength 391 nm after excitation wave length 334 nm as shown in fig. 2 .
Standard DAB (10 mg) was weighed and transferred into 10 ml volumetric flask and dissolved in dimethyl sulphoxide (DMSO). The flask was shaken and volume was made up to the mark with DMSO. Further the stock solution was diluted with DMSO to get final concentration of 10 μg/ml and fluorescence intensity quantified by spectrofluorimeter.
relative standard deviation values were found to be less than 2 for accuracy and precision studies. 
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The calibration curve was constructed by plotting the analyte fluorescence intensity against the concentration (µg/ml). Calibration curve was evaluated by its correlation coefficient. The stability of the drug was measured in DMSO and DAB was found to be stable for 72 h.
For the assay, twenty capsules of marketed formulation (Pradaxa) each containing 110 mg of DAB were taken and accurately weighed. Capsules were emptied and weight of granules was calculated by subtracting weight of each empty shell from each capsule weight. Average weight was determined and an accurately weighed quantity of granules equivalent to 10 mg of DAB was transferred into 10 ml volumetric flask and dissolved in 5 ml of DMSO and sonicated for 10 min. Then the volume is made up to mark with the DMSO and filtered through whatman filter paper. Further the filtrate was diluted with DMSO to get final concentrations within linearity range for quantification of DAB. Results were in good agreement with the label claim of the drug and reported in Table 1 . The proposed method validated according to ICH guidelines [12] .
A linear calibration plot for the method was obtained over the calibration range of 0.01-1 µg/ml at an emission wavelength of 391 nm. The equation of the regression line was found to be Y=154.1x+12.37 with a correlation coefficient of 0.987. Optimum conditions of proposed method mentioned in Table 2 . The percentage recoveries were conducted at three different levels (80, 100 and 120%) as per standard addition method and results of recovery were found to be in the range of 98.8-102.4%, indicates that the method is accurate. Results from precision expressed in terms of %RSD, found to be less than 2. No significant differences between intraday and interday precision, which indicated that the method is reproducible and reliable. The results of limit of detection (LOD) and limit of quantification (LOQ) revealed that proposed method was highly sensitive than previous methods. The % assay in commercial formulations was found to be in the range 98-102% by the proposed method and % RSD was less than 2, which indicates the accuracy of the proposed method. The results of the assay (Table 1) indicated that the method is specific for the assay of DAB without interference from excipients used in pharmaceutical formulations.
It is concluded that the contemplated method was found to be highly sensitive from the LOD and LOQ values compared to the previously reported methods and simple for the quantification of DAB in pure form and pharmaceutical dosage form. The assay values were in good agreement with their respective label claim, which suggested no interference of formulation excipients in the estimation. The results obtained from validation proved that; the proposed method was scientifically sound. These advantages encourage that the proposed method can be routinely employed in quality control for analysis of DAB in tablet formulation.
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Plumeria obtusa L. (Apocynaceae) commonly known as Gulechin, Graveyard Tree or Frangipanier [1, 2] is a small, much-branched, evergreen or partly deciduous tree [3] . The plant has been used in the management of diabetes mellitus, asthma, gonorrhea and constipation and also as a contraceptive, expectorant and anthelmintic [4] [5] [6] . The present study was undertaken to determine the antioxidant activity of methanol leaf extract and various fractions of P. obtusa.
The leaves were collected from Lucknow and identified at Central Drug Research Institute (CDRI), Lucknow. They were shade dried and powdered. Six hundred grams of plant material was soaked in methanol (6 l×3 times) at room temperature for 48 h to get methanol extract. The methanol extract was concentrated using rotary evaporator to get a residue of about 100 g. Ten grams of crude methanol extract was used for evaluating biological activities and the rest for preparing fractions using solvents such as hexane, ethyl acetate, n-butanol and distilled water. All the fractions were concentrated individually using rotary evaporator. Preliminary phytochemical analysis of extract and fractions was done using standard procedures [7] and results are given in Table 1 .
